Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 9/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.44 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL987843 | 0.90 | FAAH (0.53) | FAAHRAB9AATMMAPTSMN1; SMN2 | |
| SCHEMBL989358 | 0.88 | FAAH (0.53) | FAAHRAB9ALMNA | |
| SCHEMBL25271584 | 0.88 | RAB9A (0.60) | FAAHRAB9AATMMAPTSMN1; SMN2 | |
| SCHEMBL990751 | 0.87 | THRA (0.53) | FAAHRAB9A | |
| SCHEMBL989071 | 0.86 | THRA (0.55) | FAAH | |
| SCHEMBL989377 | 0.86 | THRA (0.55) | FAAH | |
| SCHEMBL988691 | 0.86 | THRA (0.55) | FAAH | |
| SCHEMBL25488355 | 0.84 | ATM (0.71) | FAAHRAB9AATMMAPTSMN1; SMN2 | |
| SCHEMBL980987 | 0.84 | ALDH1A1 (0.57) | FAAHRAB9AATMMAPTSMN1; SMN2 | |
| SCHEMBL9123000 | 0.80 | RAB9A (0.49) | FAAHRAB9AMAPTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192853-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| EP-2641896-B1 | SEPARATION METHOD | ASAHI CHEMICAL IND (JP) | 2020-10-14 | — | — | EP | disclosed |
| EP-2275405-B1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-2626345-B1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-9950273-B2 | Method of separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-04-19 | — | — | US | disclosed |
| US-9884810-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| US-8895774-B2 | Process for producing isocyanates using diaryl carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20140332367-A1 | Method of Separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| EP-2641896-A1 | SEPARATION METHOD | Asahi Kasei Chemicals Corporation (JP) | 2013-09-25 | — | — | EP | disclosed |
| EP-2626345-A1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20110054211-A1 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
| EP-2275405-A1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140332367-A1 | Method of Separation | CCKBR, MAOB, CA9 | FAAH 172/4885RAB9A 1046/4885ATM 2420/4885 |
| US-20110054211-A1 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE | PAH, AADAC, PHGDH | FAAH 1162/4885RAB9A 3086/4885ATM 3626/4885 |
| US-11192853-B2 | Separation method and method for producing isocyanate | IDH3A, IDH3B, CA9 | FAAH 662/4885RAB9A 1533/4885ATM 211/4885 |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | FAAH 662/4885RAB9A 1533/4885ATM 211/4885 |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | FAAH 662/4885RAB9A 1533/4885ATM 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.